Genome-wide CRISPR-Cas9 screen reveals selective vulnerability of ARID1A deficiency Hepatocellular Carcinoma

ABSTRACT: To uncover therapeutic strategies for ARID1A deficient HCC, we performed genome-scale CRISPR–Cas9 based synthetic lethality screens using ARID1A deficiency HCC cellular model

ORGANISM(S): Homo sapiens

PROVIDER: GSE228177 | GEO | 2023/09/11

REPOSITORIES: GEO